Aug 2026
Atezolizumab vs durvalumab for extensive-stage small cell lung cancer in Japan: a real-world comparative analysis of costs and clinical outcomes.
K. Hirano, Akito Hata, Y. Yamanaka et al.
· Japanese Journal of Clinical... · 0 citations